Biomecite Diagnostics has developed a diagnostic software platform that is based on the DNA signature of the total gut microbiome to diagnose patients suffering from various diseases. The company’s first application will provide gastroenterologists and general practitioners a test that will diagnose Irritable Bowel Syndrome (IBS) and distinguish types of Inflammatory Bowel Disease (IBD) with one simple at home stool collection.